Quality of oral anticoagulation with vitamin K antagonists in ‘real-world’ patients with atrial fibrillation: a report from the prospective multicentre FANTASIIA registry — María Asunción Esteve‐Pastor (2017) | RDL Network
Quality of oral anticoagulation with vitamin K antagonists in ‘real-world’ patients with atrial fibrillation: a report from the prospective multicentre FANTASIIA registry
Article 2017 en
Authors
ME
María Asunción Esteve‐Pastor
JR
José Miguel Rivera‐Caravaca
IR
Inmaculada Roldán‐Rabadán
Abstract
1 min read
In a multicentre prospective registry, 55% of AF patients had poor anticoagulation control with diabetes mellitus, PAD, and HAS-BLED being independently associated with TTR < 70%. A high SAMe-TT2R2 scores had a high specificity for predicting a TTR < 70% as an indicator of poor quality anticoagulation.
Inmaculada Roldán Rabadán, María Asunción Esteve‐Pastor, Manuel Anguita‐Sánchez, Javier Muñiz, José Camacho Siles, María Angustias Quesada, Martín Ruiz Ortiz, Francisco Marı́n, Manuel Martínez‐Sellés, Vicente Bertoméu, Professor Gregory Lip, Ángel Cequier, Lina Badimón
Vanessa Roldán, Lorena Martínez-Montesinos, Raquel López‐Gálvez, Lucía García-Tomás, Professor Gregory Lip, José Miguel Rivera‐Caravaca, Francisco Marı́n
María Asunción Esteve‐Pastor, José Miguel Rivera‐Caravaca, Inmaculada Roldán‐Rabadán, Vanessa Roldán, Javier Muñiz, Paula Raña‐Míguez, Martín Ruiz Ortiz, Ángel Cequier, Vicente Bertoméu, Lina Badimón, Manuel Anguita, Professor Gregory Lip, Francisco Marı́n
Discussion(0)
No comments yet. Be the first to comment.